Tenax Therapeutics (TENX) Finished Goods (2012 - 2014)

Tenax Therapeutics recorded quarterly Finished Goods of $68658.0 in Q1 2014, down 0.79% quarter-over-quarter from $69206.0 in Q4 2013, and down 13.27% year-over-year from $79159.0 in Q1 2013.

Tenax Therapeutics' Finished Goods history runs 3 years deep, the most recent figure standing at $68658.0 for Q1 2014.

  • In Q1 2014, Finished Goods fell 13.27% year-over-year to $68658.0; the TTM figure through Jan 2014 stood at $68658.0 (down 13.27% YoY), while the FY2013 annual figure was $70425.0, up 21.86% from the prior year.
  • Finished Goods came in at $68658.0 for Q1 2014 at Tenax Therapeutics, down from $69206.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $80578.0 in Q4 2012 to a low of $26510.0 in Q3 2012.
  • A 3-year average of $65310.5 and a median of $69681.5 in 2013 frame the typical range for Finished Goods.
  • On a YoY basis, Finished Goods climbed as much as 164.64% in 2013 and fell as far as 14.11% in 2013.
  • Tenax Therapeutics' Finished Goods stood at $80578.0 in 2012, then slipped by 14.11% to $69206.0 in 2013, then retreated by 0.79% to $68658.0 in 2014.
  • According to Business Quant data, Finished Goods over the past three periods registered $68658.0, $69206.0, and $70157.0 for Q1 2014, Q4 2013, and Q3 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Tenax Therapeutics 542.72 Mn 542.72 Mn -

Historic Data

Download Data 🔒
DateValue
Jan 31, 2014 68,658.00
Oct 31, 2013 69,206.00
Jul 31, 2013 70,157.00
Apr 30, 2013 70,425.00
Jan 31, 2013 79,159.00
Oct 31, 2012 80,578.00
Jul 31, 2012 26,510.00
Apr 30, 2012 57,791.00